Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Mar;227(3):372–379. doi: 10.1097/00000658-199803000-00009

Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.

A Schott 1, I Vogel 1, U Krueger 1, H Kalthoff 1, H W Schreiber 1, W Schmiegel 1, D Henne-Bruns 1, B Kremer 1, H Juhl 1
PMCID: PMC1191275  PMID: 9527060

Abstract

OBJECTIVE: To evaluate the prognostic significance of isolated tumor cells detected by a panel of various monoclonal antibodies. SUMMARY BACKGROUND DATA: Previously, we showed by using immunocytology that cancer cells are frequently found in bone marrow and peritoneal cavity samples of gastrointestinal cancer patients. METHODS: Findings in bone marrow and peritoneal cavity samples were compared and correlated with the 4-year survival rate of 84 gastric and 109 colorectal patients with cancer. RESULTS: Although positive results in the bone marrow showed little prognostic significance, the peritoneal cavity results correlated with the 4-year survival rate (gastric cancer: p = 0.0038; colorectal cancer: p = 0.0079). Additionally, in subgroups of patients with early (gastric cancer: p = 0.02, colorectal cancer: p = 0.48) and advanced (gastric cancer: p = 0.02, colorectal cancer: p < 0.0001) tumor stages, a correlation of immunocytologic findings and the survival rate was seen. CONCLUSIONS: The detection of minimal residual disease in the peritoneal cavity serves as a new prognostic marker.

Full text

PDF
372

Images in this article

376Figure 5.
on p.376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Combaret V., Favrot M. C., Kremens B., Philip I., Bailly C., Fontaniere B., Gentilhomme O., Chauvin F., Zucker J. M., Bernard J. L. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer. 1989 Jun;59(6):844–847. doi: 10.1038/bjc.1989.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Diel I. J., Kaufmann M., Goerner R., Costa S. D., Kaul S., Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol. 1992 Oct;10(10):1534–1539. doi: 10.1200/JCO.1992.10.10.1534. [DOI] [PubMed] [Google Scholar]
  3. Gerhard M., Juhl H., Kalthoff H., Schreiber H. W., Wagener C., Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 1994 Apr;12(4):725–729. doi: 10.1200/JCO.1994.12.4.725. [DOI] [PubMed] [Google Scholar]
  4. Hagiwara A., Takahashi T., Kojima O., Sawai K., Yamaguchi T., Yamane T., Taniguchi H., Kitamura K., Noguchi A., Seiki K. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet. 1992 Mar 14;339(8794):629–631. doi: 10.1016/0140-6736(92)90792-2. [DOI] [PubMed] [Google Scholar]
  5. Hammarstrom S., Shively J. E., Paxton R. J., Beatty B. G., Larsson A., Ghosh R., Bormer O., Buchegger F., Mach J. P., Burtin P. Antigenic sites in carcinoembryonic antigen. Cancer Res. 1989 Sep 1;49(17):4852–4858. [PubMed] [Google Scholar]
  6. Herlyn M., Steplewski Z., Herlyn D., Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438–1442. doi: 10.1073/pnas.76.3.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Juhl H., Stritzel M., Wroblewski A., Henne-Bruns D., Kremer B., Schmiegel W., Neumaier M., Wagener C., Schreiber H. W., Kalthoff H. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer. 1994 May 1;57(3):330–335. doi: 10.1002/ijc.2910570307. [DOI] [PubMed] [Google Scholar]
  8. Jung R., Ahmad-Nejad P., Wimmer M., Gerhard M., Wagener C., Neumaier M. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. Eur J Clin Chem Clin Biochem. 1997 Jan;35(1):3–10. [PubMed] [Google Scholar]
  9. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979 Nov;5(6):957–971. doi: 10.1007/BF01542654. [DOI] [PubMed] [Google Scholar]
  10. Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 1992 Sep 19;340(8821):685–689. doi: 10.1016/0140-6736(92)92230-d. [DOI] [PubMed] [Google Scholar]
  11. Lüttges J., Neumann K., Pflüger K. H., Schmitz-Moormann P. Differentialzytologie von Ergussflüssigkeiten unter Anwendung von monoklonalen Antikörpern. Pathologe. 1988 May;9(3):137–142. [PubMed] [Google Scholar]
  12. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Goodman P. J., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352–358. doi: 10.1056/NEJM199002083220602. [DOI] [PubMed] [Google Scholar]
  13. Molino A., Colombatti M., Bonetti F., Zardini M., Pasini F., Perini A., Pelosi G., Tridente G., Veneri D., Cetto G. L. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer. 1991 Feb 15;67(4):1033–1036. doi: 10.1002/1097-0142(19910215)67:4<1033::aid-cncr2820670428>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  14. Nakajima T., Harashima S., Hirata M., Kajitani T. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol. 1978 Jul-Aug;22(4):225–229. [PubMed] [Google Scholar]
  15. Nomoto S., Nakao A., Takeuchi Y., Nonami T., Harada A., Ichihara T., Takagi H. Intraoperative peritoneal washing cytology with the rapid immunoperoxidase method using microwave irradiation. J Surg Oncol. 1995 Sep;60(1):30–34. doi: 10.1002/jso.2930600107. [DOI] [PubMed] [Google Scholar]
  16. Pantel K., Izbicki J., Passlick B., Angstwurm M., Häussinger K., Thetter O., Riethmüller G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996 Mar 9;347(9002):649–653. doi: 10.1016/s0140-6736(96)91203-9. [DOI] [PubMed] [Google Scholar]
  17. Pantel K., Schlimok G., Braun S., Kutter D., Lindemann F., Schaller G., Funke I., Izbicki J. R., Riethmüller G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst. 1993 Sep 1;85(17):1419–1424. doi: 10.1093/jnci/85.17.1419. [DOI] [PubMed] [Google Scholar]
  18. Redding W. H., Coombes R. C., Monaghan P., Clink H. M., Imrie S. F., Dearnaley D. P., Ormerod M. G., Sloane J. P., Gazet J. C., Powles T. J. Detection of micrometastases in patients with primary breast cancer. Lancet. 1983 Dec 3;2(8362):1271–1274. doi: 10.1016/s0140-6736(83)91150-9. [DOI] [PubMed] [Google Scholar]
  19. Riesenberg R., Oberneder R., Kriegmair M., Epp M., Bitzer U., Hofstetter A., Braun S., Riethmüller G., Pantel K. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. Histochemistry. 1993 Jan;99(1):61–66. doi: 10.1007/BF00268022. [DOI] [PubMed] [Google Scholar]
  20. Schlimok G., Funke I., Holzmann B., Göttlinger G., Schmidt G., Häuser H., Swierkot S., Warnecke H. H., Schneider B., Koprowski H. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8672–8676. doi: 10.1073/pnas.84.23.8672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schlimok G., Funke I., Pantel K., Strobel F., Lindemann F., Witte J., Riethmüller G. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer. 1991;27(11):1461–1465. doi: 10.1016/0277-5379(91)90032-9. [DOI] [PubMed] [Google Scholar]
  22. Schmiegel W. H., Kalthoff H., Arndt R., Gieseking J., Greten H., Klöppel G., Kreiker C., Ladak A., Lampe V., Ulrich S. Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res. 1985 Mar;45(3):1402–1407. [PubMed] [Google Scholar]
  23. Soeth E., Röder C., Juhl H., Krüger U., Kremer B., Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer. 1996 Aug 22;69(4):278–282. doi: 10.1002/(SICI)1097-0215(19960822)69:4<278::AID-IJC7>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES